Detalhe da pesquisa
1.
Urinary cadmium concentration is associated with the severity and clinical outcomes of COVID-19: a bicenter observational cohort study.
Environ Health
; 23(1): 29, 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38504259
2.
Zinc deficiency associated with cutaneous toxicities induced by epidermal growth factor receptor tyrosine kinase inhibitor therapy in patients with lung adenocarcinoma.
J Eur Acad Dermatol Venereol
; 37(2): 328-339, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36366861
3.
Circulating EGFR Mutations in Patients with Lung Adenocarcinoma by Circulating Tumor Cell Isolation Systems: A Concordance Study.
Int J Mol Sci
; 23(18)2022 Sep 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36142574
4.
Feasibility and effectiveness of afatinib for poor performance status patients with EGFR-mutation-positive non-small-cell lung cancer: a retrospective cohort study.
BMC Cancer
; 21(1): 859, 2021 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34315431
5.
Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease.
Medicina (Kaunas)
; 57(11)2021 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34833378
6.
Epidermal Growth Factor Receptor (EGFR) Pathway, Yes-Associated Protein (YAP) and the Regulation of Programmed Death-Ligand 1 (PD-L1) in Non-Small Cell Lung Cancer (NSCLC).
Int J Mol Sci
; 20(15)2019 Aug 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31387256
7.
Inhibition of yes-associated protein suppresses brain metastasis of human lung adenocarcinoma in a murine model.
J Cell Mol Med
; 22(6): 3073-3085, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29575527
8.
Inhibition of yes-associated protein down-regulates PD-L1 (CD274) expression in human malignant pleural mesothelioma.
J Cell Mol Med
; 22(6): 3139-3148, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29575535
9.
Targeting YAP in malignant pleural mesothelioma.
J Cell Mol Med
; 21(11): 2663-2676, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470935
10.
Cul4A overexpression associated with Gli1 expression in malignant pleural mesothelioma.
J Cell Mol Med
; 19(10): 2385-96, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26218750
11.
Overall response to first-line tyrosine kinase inhibitor and second-line chemotherapy is predictive of survival outcome in epidermal growth factor receptor-mutated adenocarcinoma.
Chemotherapy
; 60(3): 201-10, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25871639
12.
Factors associated with prolonged progression-free survival of patients treated with first-line afatinib for advanced epidermal growth factor receptor-mutated non-small cell lung cancer.
Thorac Cancer
; 15(7): 529-537, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38279515
13.
Effectiveness and safety of afatinib, gefitinib, and erlotinib for treatment-naïve elderly patients with epidermal growth factor receptor-mutated advanced non-small-cell lung cancer: a multi-institute retrospective study.
Aging (Albany NY)
; 16(1): 550-567, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194721
14.
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
Ther Adv Med Oncol
; 16: 17588359231222604, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38249338
15.
Bevacizumab-Induced Thrombotic Microangiopathy (TMA) in Metastatic Lung Adenocarcinoma Patients Receiving Nivolumab Combined with Bevacizumab, Carboplatin and Paclitaxel: Two Case Reports.
Clin Pract
; 13(1): 200-205, 2023 Jan 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36826160
16.
The survival after discontinuation of EGFR-TKIs due to intolerable adverse events in patients with EGFR-mutated non-small cell lung cancer.
Thorac Cancer
; 14(4): 348-356, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525509
17.
Epidermal growth factor receptor tyrosine kinase inhibitors for non-small cell lung cancer harboring uncommon EGFR mutations: Real-world data from Taiwan.
Thorac Cancer
; 14(1): 12-23, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36424878
18.
Comprehensive assessment of pretreatment sarcopenia impacts on patients with EGFR-mutated NSCLC treated with afatinib.
Thorac Cancer
; 14(25): 2548-2557, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37525557
19.
Clinical outcome analysis of non-small cell lung cancer patients with brain metastasis receiving metastatic brain tumor resection surgery: a multicenter observational study.
Am J Cancer Res
; 13(8): 3607-3617, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37693127
20.
Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan.
Target Oncol
; 18(2): 195-207, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36805452